SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus

Background: Primary aldosteronism, characterized by inappropriately high and relatively autonomous aldosterone production, is one of the most frequent causes of secondary hypertension. In most cases, primary aldosteronism results from unilateral or bilateral adrenal hyperplasia and aldosterone-produ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Endocr Soc
Päätekijät: Trinh, Beckey, Hepprich, Matthias, Betz, Matthias, Burkard, Thilo, Cavelti.Weder, Claudia, Seelig, Eleonora, Meienberg, Fabian, Kratschmar, Denise, Odermatt, Alex, Michael, Hall, Donath, Marc, Swierczynska, Marta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Endocrine Society 2019
Aiheet:
Cardiovascular Endocrinology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-059
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia